Instituto Bernabeu
19
2
2
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
10.5%
2 terminated/withdrawn out of 19 trials
83.3%
-3.2% vs industry average
47%
9 trials in Phase 3/4
20%
2 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Follicular Flushing Using Double Lumen Needle Versus Direct Aspiration in Low Prognosis Patients According to the POSEIDON Criteria
Role: lead
Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.
Role: lead
Non-Invasive Preimplantation Genetic Screening for Aneuploidies and Clinical Outcomes in Egg Donation Patients
Role: lead
Continuous Double Ovarian Stimulation.
Role: lead
TRAP Study: Testosterone for Androgen Receptor Polymorphism
Role: lead
Impact of Endometrial Compaction on Reproductive Outcomes After Cryotransfer of Euploid Embryos in a Natural Cycle
Role: lead
Comparison of Triggers in Double Ovarian Stimulation (DuoStim).
Role: lead
Follicular Phase Stimulation vs. Luteal Phase Stimulation in Patients Diagnosed With Suboptimal Response
Role: lead
Vaginal Microbiome Influence on the Results of Assisted Reproduction Techniques
Role: lead
Interaction Between the Vaginal and Seminal Microbiome in Patients With an Altered Vaginal Microbiome Pattern Resistant to Treatment
Role: lead
Prospective Randomized Study to Evaluate the Effect of Embryonic Observation on the Gestation (PROdE)
Role: lead
Conventional Ovarian Stimulation vs. Single Injection Stimulation of Corifollitropin Alfa in Oocyte Donor
Role: lead
Progesterone Levels and Clinical Outcomes Using a Single Pessary of 400 mg of Vaginal Progesterone in Substitutive Cycles for Embryo Transfer.
Role: lead
The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in Oocyte Donors
Role: collaborator
Validation of a NICS Method Using the Culture Medium
Role: lead
Random-start Ovarian Stimulation in Egg-donors (ROSE)
Role: lead
Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles (LUTEAL Trial)
Role: lead
Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)
Role: lead
Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes Recipients
Role: lead
All 19 trials loaded